Latest articles
NHS staff praised as productivity grows
A study by health experts has shown that the productivity of the NHS has improved almost two and a half times faster than the...
Oxford PharmaGenesis awarded business accolade
Independent HealthScience communications consultancy Oxford PharmaGenesis has been awarded its second Queen’s Award for Enterprise, the UK’s highest accolade for business success. The consultancy was...
Advance in CAR T therapy eliminates side effects
A new University of Southern California study has found that an advance in CAR T therapy eliminates side effects and produces remissions without toxicity in...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Understanding Multiple Sclerosis (MS)
Multiple sclerosis (MS) is a neurological condition affecting the central nervous system. ‘Sclerosis’ means the scarring or hardening of tiny patches of tissue; it...
NICE publishes final recommendation for ILUMETRI ®▼
NICE has published final recommendation for ILUMETRI ®▼ (Tildrakizumab), as a cost-effective option for adults with moderate-to-severe plaque psoriasis. The National Institute for Health and Care...
Electronic prescribing to help hospitals tackle medication errors
Patientrack's parent company has entered into a reseller agreement with healthcare software provider Better by Marand to help hospitals tackle medication errors. Patientrack provides...
Seqirus to make entire influenza vaccine production process cell-based
Influenza vaccine manufacturer Seqirus is to manufacture its cell-based influenza vaccine (FLUCELVAX® TETRA) using cell-based Candidate Vaccine Viruses (CVVs) for all four strains recommended...